4Bai A,Kojima H,Hori M,et al.Priming with G-CSF effectively enhances low-dose Ara-C-induced in vivo apoptosis in myeloid leukemia cells[J].Exp Hematol,1999,27(2):259-265.
2Fukumoto JS,Greenberg PL. Management of patients with higher risk myelodysplastic syndromes [ J ]. Crit Rev Oncol Hematol, 2005,56 (2) :179 -192.
3张之南,沈悌血液病诊断及疗效标准[M].3版.北京:科学出版社,2007:122-123.
4Cheson BD, Greenberg PL, Bennett JM, et al. Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia [ J ]. Blood, 2006 ( 108 ) : 419 - 425.
5Saito K, Furusawa S, Yamada K, et al. Comparison of lowdose cytosine arabinoside and aelarubiein in combination with granuloeyte eolonystimulating factor to intermediatedose cytosine arabinoside and mitoxantrone with or without etoposide in the treatment of relapsed acute myeloid leukemia[ J]. Rinsho Ketsueki, 1995,36 ( 3 ) : 165 - 174.
6Amuguleng B, Hiroshi K, Mitsuo H, et al. Priming with G - CSF ef- fectively enhances low - dose Ara - C - induced in vivo apoptosis in myeloid leukemia cells [J]. Experimental Hematology, 1999,27 ( 2 ) : 259 - 265.
7Partyka S, Dumas P, Ajani J. Combination chemotheraphy with granulocyte - macrophage - colony stimulating in patients with locoregional and metastatic gastric adenocarcinoma[J]. Cancer, 1999,85 ( 11 ) : 2336 - 2339.
8Leone G, Rutella S,Voso MT,et al. In viva priming with granuloeyte colony - stimulating factor possibly enhances the effecl of gemtuzumabozogamicin in acute myeloid leukemia: Results of a pilot study [J]. Haematologiea,2004 ( 89 ) :634 - 636.
